KMT2A and acute myeloid leukemia: Notably, overexpression of MLL-AF9 in human HSPCs resulted in a distinct DNA methylation signature which resembles that of the MLL-AF9 AML patients [46], suggesting a close correlation between MLL fusion protein and aberrant DNA methylation in leukemic transformation.